A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy

By sjmartinez • November 20, 2024

Patel N, Karanth R, Isaacs DJ, Cohen J, Wong DJ, Delshad SD. A Case of Posterior Reversible Encephalopathy Syndrome Associated With Pembrolizumab and Cetuximab Combination Therapy. Cureus. 2024 Oct 19;16(10):e71867. doi: 10.7759/cureus.71867. PMID: 39559603; PMCID: PMC11573227.

Tags: cancer immunotherapy, Cetuximab, General Internal Medicine, hematology-oncology, Hematology/Oncology, Hospitalist, immune-related adverse event, irae, pembrolizumab side effect, posterior reversible encephalopathy syndrome, pres, Publications

Domestic violence laws and women’s unmet need for family planning: Quasi-experimental evidence from Africa

Bhuwania P, Raub A, Sprague A, Martin A, Bose B, Kidman R, Heymann J. Domestic violence laws and women's unmet need for family planning: Quasi-experimental[...]

The impact of semaglutide on liver fat assessed by serial cardiac CT scans in patients with type 2 diabetes: Results from STOP trial

Golub LS, Manubolu VS, Aldana-Bitar J, Dahal S, Verghese D, Alalawi L, Krishnan S, Kianoush S, Benzing T, Ichikawa K, Kinninger A, Fazlalizadeh H, Pourafkari[...]

Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target Trial Emulation

Watanabe A, Kuno T, Miyamoto Y, Ueyama HA, Gotanda H, Bangalore S, Tsugawa Y. Mechanical Thrombectomy vs Catheter-Directed Thrombolysis for High-Risk Pulmonary Embolism: A Target[...]